Jagsonpal Pharma (JAGSNPHARM)

STALWART

FairStock Score: 11/100 — RISKY

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹202.02
Market Cap₹1,128.24 Cr
P/E Ratio26.48
ROCE22.95%
ROE20.75%
Dividend Yield1.48%
Profit Growth-8.43%
Debt/Equity0.03
Sales Growth-1.46%
Promoter Holding67.39%
52-Week Range₹155 — ₹301.65
SectorPharmaceuticals & Biotechnology
Book Value₹29.2

Jagsonpal Pharma trades with a P/E ratio of 26.48, ROCE of 22.95%, ROE of 20.75%, profit growth of -8.43%, debt-to-equity of 0.03. The FairStock Score of 11/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer